Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Ten New Cases of Hermansky-Pudlak Syndrome in the Iberian Peninsula: Identification of Novel Genetic Variants in HPS3, HPS4, HPS6 and DTNBP1 Associated with Significant Clinical Complications

Blood (2018) 132 (Supplement 1): 1147.

https://doi.org/10.1182/blood-2018-99-112968

Published: 2018

Journal Articles

Von Willebrand Disease and Gastrointestinal Bleeding: A National Inpatient Sample (NIS) Study

Anastasia Tsagianni, MD, Margaret V. Ragni, MD MPH, Diane M. Comer, BS, Jonathan G. Yabes, PhD

Blood (2018) 132 (Supplement 1): 1179.

https://doi.org/10.1182/blood-2018-99-111731

Published: 2018

Journal Articles

Von Willebrand Factor in Angiogenesis and Angiodysplasia

Anna M Randi, MD PhD

Blood (2018) 132 (Supplement 1): SCI-43.

https://doi.org/10.1182/blood-2018-99-109556

Published: 2018

Journal Articles

von Willebrand factor regulation of blood vessel formation

Anna M. Randi, Koval E. Smith, Giancarlo Castaman

Blood (2018) 132 (2): 132–140.

https://doi.org/10.1182/blood-2018-01-769018

Published: 2018

Journal Articles

Gastrointestinal Bleeding and Angiodysplasia in Von Willebrand Disease: Results from the Ongoing French HRQoL Study: Wish-Qol

Annie Borel-Derlon, MD PhD, Dominique Desprez, MD, Fabienne Volot, MD, Herve Chambost, MD PhD, Sophie Bayard, MD, Catherine Chatelanaz, Catherine Doriat-Robin, Yves Gruel, MD PhD, Agnès Veyradier, Sr., MD PhD, Jenny Goudemand, MD PhD, Sylvia Von Mackensen, PhD

Blood (2017) 130 (Supplement 1): 4866.

https://doi.org/10.1182/blood.V130.Suppl_1.4866.4866

Published: 2017

Journal Articles

The Rate of Pregnancy Loss in Von Willebrand Disease: A Cross-Sectional Study

Leslie Skeith, MD, Natalia Rydz, MD, M. Dawn Goodyear, MD, Man-Chiu Poon, MD

Blood (2014) 124 (21): 2843.

https://doi.org/10.1182/blood.V124.21.2843.2843

Published: 2014

Journal Articles

Decreased Platelet Thrombus Size, Due to a Heightened Proteolysis of VWF By ADAMTS13, Is Quickly Restored after Valve Replacement in Aortic Stenosis Patients

Hideo Yagi, MD PhD, Masaki Hayakawa, MD, Naoko Yamaguchi, Keigo Yamashita, MD, Shigeki Taniguchi, MD PhD, Masanori Matsumoto, MD PhD, Kazuo Tsubaki, MD PhD, Yoshihiro Fujimura, MD PhD

Blood (2014) 124 (21): 2857.

https://doi.org/10.1182/blood.V124.21.2857.2857

Published: 2014

Journal Articles

Efficacy of Thalidomide in the Treatment of Severe Recurrent Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT): Preliminary Results of an Ongoing Study

Carlo L Balduini, Francesca Bellistri, Fabio Pagella, Francesco Chu, Elina Matti, Giuseppe Spinozzi, Federica Ornati, Cecilia Canzonieri, Carla Olivieri, Cesare Danesino, Marco Benazzo, Rosangela Invernizzi

Blood (2012) 120 (21): 629.

https://doi.org/10.1182/blood.V120.21.629.629

Published: 2012

Journal Articles

Inhibition of Von Willebrand Factor (VWF) by ARC1779 Normalizes Von Willebrand Factor/FVIII Levels and Corrects Thrombocytopenia in VWD Type 2b Patients,

Petra Jilma-Stohlawetz, MD, Paul Knoebl, MD, Ingrid Pabinger, MD, James Gilbert, MD, Robert G. Schaub, PhD, Bernd Jilma, MD

Blood (2011) 118 (21): 3377.

https://doi.org/10.1182/blood.V118.21.3377.3377

Published: 2011

Journal Articles

Von Willebrand Factor (VWF) Regulates Angiogenesis: Studies in Blood-Derived Endothelial Progenitor Cells From Von Willebrand's Disease Patients and VWF-Deficient Mice

Richard D Starke, PhD, Koralia Paschalaki, MD, Francesco Ferraro, PhD, Thomas A J McKinnon, PhD, Nicola H Dryden, Elspeth Payne, MBChB, Dorian O Haskard, MD PhD, Alun D Hughes, MD PhD, Daniel Cutler, PhD, Michael Laffan, MD, Anna Maria Randi, MD PhD

Blood (2011) 118 (21): 5311.

https://doi.org/10.1182/blood.V118.21.5311.5311

Published: 2011

Journal Articles

Endothelial von Willebrand factor regulates angiogenesis

Richard D. Starke, Francesco Ferraro, Koralia E. Paschalaki, Nicola H. Dryden, Thomas A. J. McKinnon, Rachel E. Sutton, Elspeth M. Payne, Dorian O. Haskard, Alun D. Hughes, Daniel F. Cutler, Mike A. Laffan, Anna M. Randi

Blood (2011) 117 (3): 1071–1080.

https://doi.org/10.1182/blood-2010-01-264507

Published: 2011

Includes: Supplemental data

Journal Articles

Report of a Case of Heyde's Syndrome Diagnosed by Abnormal Closure Times Despite Normal Von Willebrand's Activity

Pernilla D'Souza, MD, Mark Blostein, MD

Blood (2010) 116 (21): 1403.

https://doi.org/10.1182/blood.V116.21.1403.1403

Published: 2010

Journal Articles

Rapid (Sixty Minutes) Infusion of One Gram of Low Molecular Iron Dextran: Safety and Efficacy Profile.

Michael Auerbach, MD, Jennifer Pappadakis, Ph.D., Huzefa Bahrain, DO, Sandra Forrester, RN, OCN, Wendy Capitano, Naomi V. Dahl, Pharm.D.

Blood (2009) 114 (22): 4054.

https://doi.org/10.1182/blood.V114.22.4054.4054

Published: 2009

Journal Articles

Use of Recombinant Factor VIIa (rVIIa) for Treatment of Bleeding in Type II B Von Willebrand Disease: A Case Report

Arash Rezazadeh, MD, Patricia P Ashby, ARNP, Vivek R. Sharma, MD, FRCPA

Blood (2008) 112 (11): 4514.

https://doi.org/10.1182/blood.V112.11.4514.4514

Published: 2008

Journal Articles

Alterations of ADAMTS-13 Activity as a Common Indicator of the Endothelial Dysfunction Developing in Different Thrombotic Microangiopathies.

Maribel Diaz-Ricart, PhD, Marta Palomo, BSc, Carla Carbo, BSc, Arturo Pereira, MD, Marc Pino, Miquel Lozano, MD, Enric Carreras, MD, Esteban Saperas, MD, Carme Altisent, MD, Jose Aznar-Salati, PhD, Gines Escolar, MD

Blood (2006) 108 (11): 4091.

https://doi.org/10.1182/blood.V108.11.4091.4091

Published: 2006

Journal Articles

The Combined Use of Hydroxyurea and Anagrelide Allows Better Hematologic Control in Patients with Chronic Myeloproliferative Disorders and Thrombocytosis. A Report on 13 Patients with Poor Tolerance to Hydroxyurea Monotherapy.

Moira Micheletti, MD, Mariella D’Adda, MD, Monica Drera, MD, Samantha Ferrari, MSt, Giuseppe Rossi, MD

Blood (2006) 108 (11): 4892.

https://doi.org/10.1182/blood.V108.11.4892.4892

Published: 2006

Journal Articles

Management of Recurring Epistaxis in Hereditary Hemorrhagic Teleangectasia.

Giorgio Corinaldesi, MD, PhD, Christian Corinaldesi, MD

Blood (2005) 106 (11): 4061.

https://doi.org/10.1182/blood.V106.11.4061.4061

Published: 2005

NARROW

Ten New Cases of Hermansky-Pudlak Syndrome in the Iberian Peninsula: Identification of Novel Genetic Variants in HPS3, HPS4, HPS6 and DTNBP1 Associated with Significant Clinical Complications

Von Willebrand Disease and Gastrointestinal Bleeding: A National Inpatient Sample (NIS) Study

Von Willebrand Factor in Angiogenesis and Angiodysplasia

von Willebrand factor regulation of blood vessel formation

Gastrointestinal Bleeding and Angiodysplasia in Von Willebrand Disease: Results from the Ongoing French HRQoL Study: Wish-Qol

The Rate of Pregnancy Loss in Von Willebrand Disease: A Cross-Sectional Study

Decreased Platelet Thrombus Size, Due to a Heightened Proteolysis of VWF By ADAMTS13, Is Quickly Restored after Valve Replacement in Aortic Stenosis Patients

Efficacy of Thalidomide in the Treatment of Severe Recurrent Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT): Preliminary Results of an Ongoing Study

Inhibition of Von Willebrand Factor (VWF) by ARC1779 Normalizes Von Willebrand Factor/FVIII Levels and Corrects Thrombocytopenia in VWD Type 2b Patients,

Von Willebrand Factor (VWF) Regulates Angiogenesis: Studies in Blood-Derived Endothelial Progenitor Cells From Von Willebrand's Disease Patients and VWF-Deficient Mice

Endothelial von Willebrand factor regulates angiogenesis

Report of a Case of Heyde's Syndrome Diagnosed by Abnormal Closure Times Despite Normal Von Willebrand's Activity

Rapid (Sixty Minutes) Infusion of One Gram of Low Molecular Iron Dextran: Safety and Efficacy Profile.

Use of Recombinant Factor VIIa (rVIIa) for Treatment of Bleeding in Type II B Von Willebrand Disease: A Case Report

Alterations of ADAMTS-13 Activity as a Common Indicator of the Endothelial Dysfunction Developing in Different Thrombotic Microangiopathies.

The Combined Use of Hydroxyurea and Anagrelide Allows Better Hematologic Control in Patients with Chronic Myeloproliferative Disorders and Thrombocytosis. A Report on 13 Patients with Poor Tolerance to Hydroxyurea Monotherapy.

Management of Recurring Epistaxis in Hereditary Hemorrhagic Teleangectasia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only